Understanding Mesothelioma Drug Interactions: A Comprehensive Guide
#Understanding #Mesothelioma #Drug #Interactions #Comprehensive #Guide
Understanding Mesothelioma Drug Interactions: A Comprehensive Guide
Let's be brutally honest right from the get-go: when you or a loved one receives a mesothelioma diagnosis, your world gets turned upside down. The focus, rightly so, shifts to survival, to fighting this relentless beast with every fiber of your being. You're bombarded with medical jargon, treatment plans, and a whirlwind of emotions. Amidst all of this, there's a critical, often overlooked, layer of complexity that absolutely must be understood: drug interactions.
I've seen it countless times, and believe me, it’s not just a footnote in a prescription leaflet; it’s a potential minefield. Understanding how different medications, supplements, and even certain foods can interact with each other isn't just about avoiding a minor inconvenience. For mesothelioma patients, it's about safeguarding their treatment efficacy, minimizing side effects, and, frankly, ensuring their overall safety and quality of life. We're talking about the difference between a therapy working optimally versus being dangerously ineffective or causing severe, unforeseen complications. This isn't theoretical; it's real-world, life-and-death stuff. So, buckle up. We're going to dive deep into this, because knowledge, in this fight, is truly power.
The Fundamentals of Drug Interactions in Mesothelioma Treatment
Alright, let's strip away the medical mystique for a moment and talk plainly. What exactly is a drug interaction? Simply put, it's when one substance alters the expected effect of another. It could be a prescription medication messing with another prescription medication (a drug-drug interaction), or a medication reacting badly with something you ate (drug-food interaction), or even an herbal remedy or vitamin supplement throwing a wrench into your carefully calibrated treatment plan (drug-supplement interaction). It’s like having two chefs in a kitchen, each with their own idea of how to make a dish. Sometimes they complement each other beautifully, creating something exquisite. Other times, they clash spectacularly, ruining the meal entirely.
Now, why are mesothelioma patients uniquely vulnerable to these interactions? This isn't just any cancer; it's a particularly aggressive and complex one, often diagnosed at advanced stages. That means the treatment regimens are rarely simple. We're talking multi-modal approaches – a combination of chemotherapy, possibly immunotherapy, sometimes targeted therapies, radiation, and surgery. Each of these components comes with its own arsenal of drugs, and that's before we even consider the supportive care medications. Think pain relievers, anti-nausea drugs, blood thinners, antacids, corticosteroids – the list goes on. This cocktail of medications, often referred to as polypharmacy, creates a perfect storm for potential interactions. It's like juggling a dozen flaming torches while riding a unicycle – incredibly precarious.
Furthermore, many mesothelioma patients, given the nature of the disease and its typical demographic, often have pre-existing health conditions, or comorbidities. They might be managing heart disease, diabetes, kidney issues, or liver problems. These conditions can significantly alter how the body processes medications, making them more susceptible to adverse reactions or interactions. If your liver isn't functioning at 100%, it might not metabolize a drug as quickly as expected, leading to higher, potentially toxic, levels in your system. If your kidneys are struggling, eliminating drugs becomes a slower process, again increasing the risk of accumulation. It's a delicate balance, one that requires constant vigilance and a keen understanding of every single input. Neglecting this crucial aspect is like trying to navigate a dense fog without a compass – you're just asking for trouble.
Types and Mechanisms of Drug Interactions
Okay, let's get a little deeper into the "how" of these interactions. It’s not just random; there are specific pathways, specific mechanisms by which drugs can influence each other. Broadly, we categorize them into two main types: pharmacokinetic and pharmacodynamic interactions. Don't let the fancy words scare you; I'll break them down. Think of it like this: pharmacokinetics is what the body does to the drug, and pharmacodynamics is what the drug does to the body. Understanding this distinction is crucial because it helps pinpoint where the interference is happening and, consequently, how to manage or prevent it.
First, let's tackle pharmacokinetic interactions. This is all about the journey of a drug through your body – how it gets in, moves around, gets processed, and eventually leaves. We can break this down into four key stages, often remembered by the acronym ADME: Absorption, Distribution, Metabolism, and Excretion. Each of these stages is a potential point of interaction. For instance, absorption is how the drug gets from where you take it (usually your gut) into your bloodstream. If you take an antacid with certain chemotherapy drugs, the antacid might change the pH level in your stomach, making it harder for the chemo drug to be absorbed properly. Or, some drugs might bind to others in the gut, forming a complex that can't be absorbed, essentially canceling out their effect. I remember a case where a patient was taking iron supplements with an antibiotic, and they wondered why the antibiotic wasn't working. Turns out, the iron was chelating (binding to) the antibiotic, preventing its absorption. A simple timing adjustment made all the difference.
Next up is distribution, which is how the drug travels from your bloodstream to its target tissues. Many drugs travel bound to proteins in your blood, like little taxis. If two drugs compete for the same taxi, one might get bumped off, leaving more of the "free" drug floating around. This free drug is the active form, and if there's too much of it, it can lead to increased side effects or toxicity. Then we have metabolism, which is often the biggest culprit in drug interactions. This is primarily done by your liver, using a family of enzymes called the cytochrome P450 (CYP450) system. Some drugs can either inhibit these enzymes, meaning they slow down the metabolism of other drugs, leading to higher levels. Or, they can induce them, speeding up metabolism, causing other drugs to be cleared too quickly and become ineffective. It's a complex enzymatic dance, and a misstep can have serious consequences. Finally, excretion is how your body gets rid of the drug, mainly through your kidneys. If one drug interferes with the kidneys' ability to filter or excrete another, that second drug can build up to toxic levels. Think about it: if your drain is clogged, the sink fills up. Same principle.
Pro-Tip: The CYP450 System is Your Liver's Workhorse!
This enzyme system is responsible for metabolizing about 75% of all medications. Understanding if your cancer drugs or supportive care meds are substrates, inhibitors, or inducers of specific CYP450 enzymes (like CYP3A4, CYP2D6, CYP2C9) can explain a huge number of potential interactions. Always ask your pharmacist if any of your medications are known to affect or be affected by this system.
Now, let's pivot to pharmacodynamic interactions. This type of interaction isn't about how the body handles the drug, but rather how the drugs act on the body together. They influence the same physiological system or have competing or synergistic effects at the receptor level. These interactions can be a bit more insidious because they don't necessarily involve altered drug levels in the blood; they involve altered effects. One common scenario is an additive or synergistic effect. This is when two drugs, taken together, produce an effect that is equal to (additive) or greater than (synergistic) the sum of their individual effects. For example, taking two different types of CNS depressants (like an opioid painkiller and an anti-anxiety medication) can lead to profoundly increased sedation, respiratory depression, and cognitive impairment – a dangerous combination, especially for someone already weakened by cancer. It's like pressing two accelerator pedals at once.
On the flip side, you can have antagonistic effects, where one drug directly opposes or cancels out the effect of another. Imagine trying to start a fire while someone else is pouring water on it. This can lead to a drug becoming less effective or completely useless. For instance, certain steroids might counteract the effects of some immunotherapies if given concurrently, dampening the immune response that the immunotherapy is trying to boost. It’s a direct conflict of interest within the body. Another form of pharmacodynamic interaction is when drugs alter receptor sensitivity. One drug might make the body's receptors more or less sensitive to another drug, changing its potency. These interactions are often harder to predict and monitor because they don't show up on a simple blood test measuring drug levels. They manifest as unexpected changes in symptoms or treatment response, making open communication with your medical team absolutely paramount. It’s a subtle ballet of molecular biology, and any misstep can throw the whole performance off.
Common Drug Classes in Mesothelioma Treatment and Their Interaction Risks
Alright, let's get practical. Mesothelioma treatment isn't a one-size-fits-all affair. It's a complex, often individualized, strategy that typically involves a cocktail of powerful medications. Each class of drug, while vital for fighting the cancer or managing symptoms, carries its own unique interaction profile. It’s like assembling a high-performance racing engine; every single part has to work in harmony with the others, or the whole thing grinds to a halt, or worse, explodes. Understanding these risks isn't about fear-mongering; it's about informed vigilance. We need to look at the big players – the chemotherapy agents, the immunotherapies, the targeted therapies – and then, crucially, the often-overlooked supportive care medications that patients rely on daily.
The sheer volume of drugs involved in a typical mesothelioma patient's regimen is astounding. You might be on a platinum-based chemotherapy, an antimetabolite, and an immunotherapy, all at once. Then add anti-nausea medication, pain medication, blood thinners to prevent clots (a common issue in cancer patients), possibly antidepressants or sleep aids, and maybe something for heartburn. Suddenly, you've got ten or more medications circulating in your system, each with the potential to influence the others. This isn't just about avoiding a stomach ache; it's about ensuring your primary cancer-fighting drugs are working effectively and not causing undue harm. It's a delicate dance on a very thin tightrope, and every step needs to be calculated. My advice? Assume every new medication, every supplement, every dietary change has the potential for an interaction until proven otherwise by a qualified professional. That level of caution isn't paranoia; it's prudence.
Chemotherapy Agents and Their Interaction Profiles
Chemotherapy agents are the heavy artillery in the fight against mesothelioma. They're designed to be potent, to kill rapidly dividing cancer cells. But because they're so powerful, their interaction profiles can be particularly significant. Let's talk about some of the common ones.
Pemetrexed (Alimta) is a cornerstone for many mesothelioma patients. It’s an antifolate drug, meaning it interferes with the cancer cells' ability to grow. A major interaction concern with pemetrexed involves NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) like ibuprofen, naproxen, or even high-dose aspirin. Why? Because NSAIDs can reduce the kidneys' ability to clear pemetrexed from the body, leading to higher, potentially toxic levels and increased side effects like bone marrow suppression or kidney damage. This isn't a minor issue; it's a serious one that can lead to dose-limiting toxicities. Patients are typically advised to avoid NSAIDs for a few days before, during, and after pemetrexed administration. Furthermore, proton pump inhibitors (PPIs), commonly used for heartburn, can also theoretically impact pemetrexed by altering gastric pH, though clinical significance varies. It's a nuanced discussion to have with your oncologist and pharmacist.
Then we have the platinum-based drugs, Cisplatin and Carboplatin. These are classic chemotherapy agents, very effective but also notorious for their side effects. A key interaction risk here involves nephrotoxic drugs – medications that can harm the kidneys. Since platinum drugs themselves are nephrotoxic, combining them with other kidney-damaging agents (like certain antibiotics, diuretics, or even some contrast dyes used in imaging) can exacerbate kidney injury. Similarly, they can be ototoxic (harmful to hearing), so co-administration with other ototoxic drugs, such as certain loop diuretics or aminoglycoside antibiotics, needs careful consideration. Even some common antiemetics (anti-nausea drugs) can interact, particularly those that prolong the QT interval on an EKG, increasing the risk of heart rhythm abnormalities. This is why hydration protocols and careful monitoring are so critical with these drugs.
Gemcitabine is another antimetabolite often used in mesothelioma. While generally well-tolerated, it shares some interaction concerns with other antimetabolites and nucleoside analogs, as they can have overlapping toxicities or compete for similar metabolic pathways. The key takeaway with all chemotherapy is that they are powerful drugs with narrow therapeutic windows. Any interaction that pushes their levels too high or too low can have profound consequences on efficacy or safety.
Immunotherapy agents, such as Nivolumab, Ipilimumab, or Pembrolizumab, have revolutionized cancer treatment, including mesothelioma. These drugs work by unleashing the body's own immune system against cancer. Here, the interaction risks are slightly different. The biggest concern often revolves around anything that suppresses the immune system. For example, corticosteroids, while sometimes necessary to manage immunotherapy-related side effects, can blunt the effectiveness of the immunotherapy if used indiscriminately or at high doses. It's a delicate balance: you might need steroids to manage an autoimmune-like reaction, but you don't want to turn off the very immune response you're trying to activate against the cancer. Certain antibiotics can also interfere with the gut microbiome, which is increasingly recognized as playing a role in immunotherapy response. And, of course, the ever-present danger of herbal remedies that claim to "boost immunity" but might actually interfere with the precise mechanisms of these sophisticated drugs.
Finally, targeted therapies, like Bevacizumab (an anti-angiogenic agent sometimes used off-label or in trials for mesothelioma), also have their interaction nuances. Bevacizumab can increase the risk of bleeding, so combining it with anticoagulants (blood thinners) or antiplatelet agents requires extreme caution and meticulous monitoring. The risk of hemorrhage becomes significantly elevated, and what might be a routine dose of a blood thinner for another patient could be dangerous for someone on a targeted therapy affecting blood vessels.
Insider Note: The "Just a Tylenol" Trap
I've seen patients get into trouble by thinking "it's just Tylenol" or "it's just ibuprofen." While generally safe, even seemingly innocuous OTC pain relievers can have significant interactions with chemotherapy or blood thinners. Always, and I mean always, clear every single medication, even OTCs, with your oncology team. Your life literally depends on it.
Supportive Care Medications and Their Interaction Potential
Beyond the primary cancer treatments, there's a whole category of medications that are absolutely essential for managing the symptoms and side effects of mesothelioma and its therapies: supportive care drugs. These are the unsung heroes, keeping patients comfortable and able to tolerate treatment. But don't let their "supportive" role fool you; they are potent drugs themselves and carry significant interaction risks, often compounding the complexity.
Let's start with pain management. Mesothelioma can be incredibly painful, requiring powerful analgesics. Opioids are often necessary, but they come with a laundry list of potential interactions. Combining opioids with other CNS depressants like anti-anxiety medications (benzodiazepines), sleep aids, or even certain antihistamines can lead to profound sedation, respiratory depression (where you stop breathing adequately), and dangerous cognitive impairment. This isn't just about feeling drowsy; it's about potentially life-threatening suppression of vital functions. Furthermore, some opioids can interact with SSRIs (antidepressants) to increase the risk of serotonin syndrome, a potentially severe condition. And as we discussed, NSAIDs are a double-edged sword: great for pain and inflammation, but a big no-no with pemetrexed and a risk factor for gastrointestinal bleeding, especially when combined with other drugs that affect clotting.
Antiemetics are another crucial class, battling the relentless nausea and vomiting that often accompany chemotherapy. Drugs like ondansetron (Zofran) are widely used. However, some antiemetics, particularly the 5-HT3 antagonists, can prolong the QT interval on an EKG, which increases the risk of serious heart rhythm disturbances. This risk is amplified if taken with other medications that also prolong the QT interval, such as certain antibiotics, antipsychotics, or even some other anti-nausea drugs. It's a cumulative effect, and for someone with a compromised heart or electrolyte imbalances, it can be extremely dangerous.
Anticoagulants and Antiplatelets are frequently prescribed for cancer patients due to the increased risk of blood clots. Medications like warfarin (Coumadin), rivaroxaban (Xarelto), apixaban (Eliquis), or even daily aspirin, are common. The interaction potential here is enormous and critical. Combining these with NSAIDs significantly increases the risk of gastrointestinal bleeding. Many antibiotics can potentiate warfarin's effect, leading to excessive bleeding. Certain antifungals, antidepressants, and even common herbal supplements like ginkgo biloba or high-dose vitamin E can thin the blood further, creating a dangerously high bleeding risk. It’s a constant tightrope walk to prevent clots without causing a hemorrhage.
Corticosteroids (like dexamethasone or prednisone) are workhorses in oncology, used for everything from managing inflammation and allergic reactions to reducing brain swelling and boosting appetite. But they interact with a multitude of drugs. Combining them with NSAIDs dramatically increases the risk of gastric ulcers and bleeding. They can also affect blood sugar levels, necessitating careful monitoring if a patient is on antidiabetic medications. Furthermore, long-term steroid use can lead to bone loss, which can be exacerbated by other medications or conditions.
Even seemingly benign medications like laxatives and stool softeners, often needed to combat opioid-induced constipation, can have subtle but important interactions. Overuse can lead to electrolyte imbalances, which can affect heart function and the efficacy of other drugs. And antacids or proton pump inhibitors (PPIs), while excellent for heartburn, can significantly alter gastric pH, thereby impacting the absorption of many other drugs, including certain chemotherapy agents, iron supplements, and some antifungals. If a drug needs an acidic environment to dissolve and be absorbed, and you neutralize that acid, the drug simply won't work as intended. It’s a domino effect, where one seemingly small intervention can have far-reaching consequences throughout the body's intricate chemistry.
Non-Prescription Interactions: OTCs, Supplements, and Food
This is where things get really tricky, and frankly, where patients often get into trouble without even realizing it. We're so conditioned to think of "medicine" as something a doctor prescribes, but the reality is, many of us regularly self-medicate with over-the-counter (OTC) products, vitamins, herbal supplements, and even specific foods, without considering their potential impact on a complex treatment regimen. This casual approach can be incredibly dangerous for mesothelioma patients. It’s like trying to fix a sophisticated machine with tools from your kitchen drawer – you might do more harm than good.
Let's start with OTC medications. We've already touched on NSAIDs (ibuprofen, naproxen), but they bear repeating because they are so ubiquitous. Patients might grab them for a headache or muscle pain, unaware of their potential to cause kidney damage, increase bleeding risk with blood thinners, or interfere with chemotherapy like pemetrexed. Then there are antacids (Tums, Rolaids, Maalox), which can alter stomach pH and affect the absorption of countless other drugs. Cold and flu remedies are another minefield. Many contain decongestants that can raise blood pressure, or antihistamines that can cause sedation, which is a dangerous additive effect if you're already on opioid pain relievers or anti-anxiety meds. Some even contain hidden doses of acetaminophen, which, if combined with prescription acetaminophen, can lead to liver toxicity. The key here is that "non-prescription" does not equate to "non-pharmacological" or "harmless." They are still drugs, and they interact like drugs.
Now, let's talk about herbal supplements. Oh, the wild west of wellness! Patients, understandably, are often looking for anything that might help them feel better, boost their immune system, or combat side effects. But many herbal remedies have potent pharmacological effects and can interact profoundly with conventional medications. St. John's Wort, commonly used for depression, is a notorious enzyme inducer, meaning it can speed up the metabolism of many drugs, including some chemotherapy agents and blood thinners, making them less effective. Grapefruit and grapefruit juice contain compounds that inhibit a specific CYP450 enzyme (CYP3A4) in the gut, leading to increased levels of many drugs, including some targeted therapies, statins, and blood pressure medications. This can lead to exaggerated side effects and toxicity. Ginkgo Biloba and high-dose vitamin E can increase bleeding risk, a serious concern for patients on anticoagulants or antiplatelets. Even seemingly innocuous things like turmeric (curcumin) or green tea extract can have antiplatelet effects or interact with chemotherapy metabolism. The problem is that these products are often unregulated, their active ingredients vary, and their potential interactions are not always well-documented or understood by the general public, or even some healthcare providers outside of specialized oncology pharmacy.
Numbered List: Common Culprits in Drug-Supplement Interactions
- St. John's Wort: Can decrease the effectiveness of many chemotherapy drugs, immunosuppressants, and anticoagulants by speeding up their metabolism.
- Grapefruit/Grapefruit Juice: Can increase the levels of certain targeted therapies, statins, and blood pressure medications by inhibiting their metabolism, leading to toxicity.
- Ginkgo Biloba & High-Dose Vitamin E: Can increase bleeding risk when taken with anticoagulants or antiplatelet agents.
- Green Tea Extract: May interfere with certain chemotherapy agents (e.g., bortezomib) and can have antiplatelet effects.
- Echinacea: While often touted for immune support, it can interact with immunosuppressants and may not be advisable during immunotherapy.
And then there's food. Yes, even what you eat can be a factor. We've mentioned grapefruit juice. Another classic example is Vitamin K-rich foods (like leafy green vegetables such as spinach, kale, broccoli) and their interaction with warfarin. Vitamin K is essential for blood clotting, so consuming large, inconsistent amounts of these foods can make warfarin less effective, increasing the risk of clots. The key isn't to avoid them entirely, but to maintain a consistent intake. Tyramine-rich foods (aged cheeses, cured meats, fermented products) can cause dangerously high blood pressure spikes if consumed by patients on certain older antidepressants (MAOIs), though these are less commonly used in oncology. Even the timing of food intake relative to medication can matter. Some drugs need to be taken on an empty stomach for optimal absorption, while others need food to prevent stomach upset or enhance absorption.
Finally, we cannot ignore alcohol and recreational drugs. Alcohol, even in moderate amounts, can interact with countless medications. It's a CNS depressant, so combining it with opioids or anti-anxiety meds dramatically increases sedation and respiratory depression. It's also metabolized by the liver, competing with or interfering with the metabolism of other drugs, potentially leading to liver damage or altered drug levels. Recreational drugs are an even greater unknown, with unpredictable interactions and potential for severe adverse events. The honest truth is, during mesothelioma treatment, alcohol and recreational drugs are best avoided entirely. Your body is already under immense stress, and adding these variables can dangerously complicate your treatment and recovery.
The Perils of Polypharmacy and Comorbidities
Okay, let's pull back and look at the bigger picture, because the individual interactions we've discussed don't happen in a vacuum. They accumulate, they intertwine, and they create a complex web of risk, especially for mesothelioma patients. This brings us to the concept of polypharmacy, which is essentially the simultaneous use of multiple medications by a patient. While there's no single magic number, it's generally defined as taking five or more prescription medications concurrently. For cancer patients, particularly those with a complex disease like mesothelioma, polypharmacy is not just common; it's almost inevitable. Think about it: specific chemotherapy, immunotherapy, anti-nausea, pain control, blood clot prevention, heartburn relief, perhaps something for anxiety or sleep, and then throw in medications for pre-existing conditions like high blood pressure or diabetes. It's easy to hit ten or more drugs without even trying.
The problem with polypharmacy isn't just the sheer number of pills; it's the exponential increase in the likelihood of drug interactions. The more drugs you add, the more potential points of conflict you introduce. It's not a linear increase; it's more like a geometric progression. One drug interacting with another is one thing. One drug interacting with two others, and those two interacting with each other, and then a fourth drug interacting with all three – it becomes a dizzying cascade of potential problems. Each interaction, even a seemingly minor one, can contribute to a patient's overall "drug burden," increasing the risk of side effects, reducing efficacy, and diminishing quality of life. I've witnessed situations where a patient's fatigue or confusion was attributed solely to their cancer or chemotherapy, only for a thorough medication review to reveal a cocktail of interacting drugs as the primary culprit. It's a real eye-opener.
Compounding the issue of polypharmacy are comorbidities, those other health conditions that many mesothelioma patients are managing simultaneously. Renal (kidney) and hepatic (liver) impairment are particularly significant. These organs are the body's primary filters and processing plants for drugs. If they're not functioning optimally, drugs can accumulate to toxic levels or be cleared too quickly. A patient with pre-existing kidney disease, for instance, will metabolize and excrete certain chemotherapy drugs and supportive medications differently than someone with healthy kidneys. Doses often need to be adjusted, and monitoring becomes even more critical. Similarly, liver disease can profoundly impact drug metabolism, making enzyme-mediated interactions even more unpredictable and dangerous.
Cardiovascular disease (heart conditions), diabetes, and respiratory issues are also common comorbidities that add layers of complexity. Medications for these conditions can interact with cancer treatments or supportive care drugs. For example, some chemotherapy agents can be cardiotoxic, meaning they can damage the heart. If a patient already has a history of heart disease, the risks are amplified, and the interaction potential with their existing cardiac medications becomes a crucial consideration. Diabetics on insulin or oral hypoglycemics need careful monitoring because corticosteroids, often used in cancer treatment, can raise blood sugar levels, requiring adjustments to their diabetes regimen.
Pro-Tip: The "Brown Bag Review"
If you or your loved one is on multiple medications, gather all of them—prescription, OTC, supplements, even samples—into a bag and bring them to every doctor's appointment and definitely to your pharmacist. Ask for a "brown bag review." This visual aid helps healthcare providers see exactly what you're taking and identify potential overlaps or interactions. It's surprisingly effective.
Let's not forget age-related factors. Mesothelioma often affects older individuals, and aging itself brings physiological changes that can impact drug handling. Older adults often have reduced kidney and liver function, altered body composition (less muscle, more fat), and increased sensitivity to drug effects. This means they are inherently more susceptible to drug interactions and adverse drug reactions, even with standard doses. What might be a safe dose for a younger patient could be problematic for an elderly one.
The cumulative effect of multiple interactions is what truly makes polypharmacy and comorbidities a perilous landscape. It's not just 1+1=2; it's often 1+1=3, or even 5. One drug might slightly increase the level of another, which then slightly increases the side effects of a third, and suddenly you have a cascade of adverse events that are difficult to untangle. This can lead to increased hospitalizations, reduced adherence to treatment (because patients feel so unwell), and a significant decline in quality of life. The mental and physical burden on the patient is immense. It underscores the absolute necessity of a holistic, vigilant approach to medication management throughout the mesothelioma journey.
Strategies for Mitigating Drug Interaction Risks
Given the veritable minefield that drug interactions present for mesothelioma
